33
/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
September 30, 2024
5499509
519327
2

jan 1, 2014 - $100 million from Alexion Pharmaceuticals

Description:

Alexion Pharmaceuticals paid Moderna $100 million for ten product options to develop rare disease treatments, including for Crigler-Najjar syndrome, using Moderna's mRNA therapeutics platform

Added to timeline:

7 Jun 2021
0
0
174

Date:

jan 1, 2014
Now
~ 11 years ago